U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07211516) titled 'Relationship Between Cognition, Workforce Participation and Well-Being in Individuals With Multiple Sclerosis' on Sept. 22.

Brief Summary: Multiple sclerosis (MS) is a chronic neurodegenerative disease and a leading cause of reduced workforce participation due to neurological illness in Western countries. Over the past 30 years, new treatments have reduced symptom burden, allowing patients to stay in the workforce longer. However, fatigue and cognitive impairments remain major barriers to work capacity. This project aims to examine factors important for work ability and well-being in persons with MS and cognitive impairments. The spe...